Single-source·Aug 22, 2026·1 sources analyzed

First-in-class therapy targets 'undruggable' protein in hard-to-treat blood cancers

First-in-class therapy targets 'undruggable' protein in hard-to-treat blood cancers (medicalxpress)

Image: medicalxpress

Sources used · 1 source

First-in-class therapy targets 'undruggable' protein in hard-to-treat blood cancers | Modern Action